Radiation-induced second malignancies (RISM) is one of the important late side effects of
radiation therapy and has an impact on optimal treatment decision-making. Many factors …

Radiation therapy (RT) is the most effective single modality for local control of Hodgkin
lymphoma (HL) and an important component of therapy for many patients. These guidelines …

Purpose Patients who receive combined modality treatment for stage I and II Hodgkin
lymphoma (HL) have an excellent outcome. Early response evaluation with positron …

Background Combined-modality treatment consisting of chemotherapy and consolidation
radiotherapy is standard of care for patients with early-stage unfavourable Hodgkin …

Hodgkin lymphoma (HL) is an uncommon malignancy of B-cell origin. Classical HL (cHL)
and nodular lymphocyte–predominant HL are the 2 main types of HL. The cure rates for HL …

PURPOSE Combined-modality treatment (CMT) with 2× ABVD (doxorubicin, bleomycin,
vinblastine, and dacarbazine) and small-field radiotherapy is standard of care for patients …

Purpose Combined-modality treatment is standard treatment for patients with clinical stage
I/II Hodgkin lymphoma (HL). We hypothesized that an early positron emission tomography …

The NCCN Clinical Practice Guidelines in Oncology for Hodgkin Lymphoma (HL) provide
recommendations for the management of adult patients with HL. The NCCN panel meets at …

The Warburg effect is characterised by increased glucose uptake and lactate secretion in
cancer cells resulting from metabolic transformation in tumour tissue. The corresponding …

PURPOSE: This multicentre, prospective, randomised-controlled trial compared efficacy and
toxicity of differing radiotherapy doses in non-Hodgkin lymphoma (NHL). PATIENTS AND …